Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 Randomized, Multicentre, Phase II Trial

NCT06297902 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06297902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06297902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 Randomized, Multicentre, Phase II Trial
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 19, 2024
Completion date
June 30, 2030
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, radiotherapy side effect